News
The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...
ZME Science on MSN2d
This mRNA HIV Vaccine Produces the Virus-Fighting Antibodies That Have Eluded Researchers for 40 Years
In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects ...
Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
Moderna's mRNA tech could change the game in the decades-long effort to develop an HIV vaccine. The company said it expects to begin two vaccine trials in humans by the end of 2021.
The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback